Patents by Inventor Nicolai Juul Birkbak

Nicolai Juul Birkbak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR PREDICTING ANTI-CANCER RESPONSE
    Publication number: 20220186311
    Abstract: The present invention is based, in part, on the identification of novel methods for defining predictive biomarkers of response to anti-cancer drugs.
    Type: Application
    Filed: March 1, 2022
    Publication date: June 16, 2022
    Applicants: Children's Medical Center Corporation, The Technical University of Denmark, Dana-Farber Cancer Institute, Inc., The Brigham and Women's Hospital, Inc.
    Inventors: Zoltan SZALLASI, Nicolai Juul BIRKBAK, Aron EKLUND, Daniel SILVER, Zhigang WANG, Andrea RICHARDSON
  • METHOD OF PREDICTING SURVIVAL RATES FOR CANCER PATIENTS
    Publication number: 20220136063
    Abstract: The present invention provides a method for providing a prognosis for a subject with lung cancer, the method comprising: (a) contacting a biological sample from the subject with reagents that specifically bind to each member of a panel of biomarkers comprising ANLN, ASPM, CDCA4, ERRFI1, FURIN, GOLGA8A, ITGA6, JAG1, LRP12, MAFF, MRPS17, PLK1, PNP, PPP1 R13L, PRKCA, PTTG1, PYGB, RPP25, SCPEP1, SLC46A3, SNX7, TPBG, XBP1; (b) determining a riskscore of the subject based on the nucleic acid levels of expression of the biomarkers in the samples; and (c) providing a prognosis for the lung cancer based on the risk score of the subject.
    Type: Application
    Filed: January 30, 2020
    Publication date: May 5, 2022
    Inventors: Robert Charles Swanton, Dhruva Biswas, Nicholas McGranahan, Nicolai Juul Birkbak
  • Methods for predicting anti-cancer response
    Patent number: 11299782
    Abstract: The present invention is based, in part, on the identification of novel methods for defining predictive biomarkers of response to anti-cancer drugs.
    Type: Grant
    Filed: December 28, 2018
    Date of Patent: April 12, 2022
    Assignees: Children's Medical Center Corporation, The Technical University of Denmark, Dana-Farber Cancer Institute, Inc., The Brigham and Women's Hospital, Inc.
    Inventors: Zoltan Szallasi, Nicolai Juul Birkbak, Aron Eklund, Daniel Silver, Zhigang Wang, Andrea Richardson
  • Methods for predicting anti-cancer response
    Patent number: 10577662
    Abstract: The present invention is based, in part, on the identification of novel methods for defining predictive biomarkers of response to anti-cancer drugs.
    Type: Grant
    Filed: October 20, 2016
    Date of Patent: March 3, 2020
    Assignees: Dana-Farber Cancer Institute, Inc., The Brigham and Women's Hospital, Inc., Children's Medical Center Corporation, The Technical University of Denmark
    Inventors: Andrea L. Richardson, Zhigang C. Wang, Daniel P. Silver, Zoltan Szallasi, Nicolai Juul Birkbak, Aron Charles Eklund
  • METHODS FOR PREDICTING ANTI-CANCER RESPONSE
    Publication number: 20190136318
    Abstract: The present invention is based, in part, on the identification of novel methods for defining predictive biomarkers of response to anti-cancer drugs.
    Type: Application
    Filed: December 28, 2018
    Publication date: May 9, 2019
    Inventors: Zoltan SZALLASI, Nicolai Juul BIRKBAK, Aron EKLUND, Daniel SILVER, Zhigang WANG, Andrea RICHARDSON
  • Methods for predicting anti-cancer response
    Patent number: 10190160
    Abstract: The present invention is based, in part, on the identification of novel methods for defining predictive biomarkers of response to anti-cancer drugs.
    Type: Grant
    Filed: August 22, 2014
    Date of Patent: January 29, 2019
    Assignees: Children's Medical Center Corporation, The Technical University of Denmark, Dana-Farber Cancer Institute, Inc., The Brigham and Women's Hospital, Inc.
    Inventors: Zoltan Szallasi, Nicolai Juul Birkbak, Aron Eklund, Daniel Silver, Zhigang Wang, Andrea Richardson
  • METHOD FOR IDENTIFICATION OF TISSUE OR ORGAN LOCALIZATION OF A TUMOUR
    Publication number: 20170342500
    Abstract: The invention relates to a method for predicting the localization of a primary tumour, wherein said method comprises the use of genomic profile data, and wherein the method is capable of predicting the type of cancer by a classification score ranking among a variety of the possible tumour types.
    Type: Application
    Filed: December 18, 2015
    Publication date: November 30, 2017
    Inventors: Andrea Marion Marquard, Aron Charles Eklund, Nicolai Juul Birkbak, Zoltan Imre Szallasi
  • METHODS FOR PREDICTING ANTI-CANCER RESPONSE
    Publication number: 20170037478
    Abstract: The present invention is based, in part, on the identification of novel methods for defining predictive biomarkers of response to anti-cancer drugs.
    Type: Application
    Filed: October 20, 2016
    Publication date: February 9, 2017
    Applicants: DANA-FARBER CANCER INSTITUTE, INC., THE BRIGHAM AND WOMEN'S HOSPITAL, INC., CHILDREN'S MEDICAL CENTER CORPORATION, THE TECHNICAL UNIVERSITY OF DENMARK
    Inventors: Andrea L. Richardson, Zhigang C. Wang, Daniel P. Silver, Zoltan Szallasi, Nicolai Juul Birkbak, Aron Charles Eklund
  • Methods for predicting anti-cancer response
    Patent number: 9512485
    Abstract: The present invention is based, in part, on the identification of novel methods for defining predictive biomarkers of response to anti-cancer drugs.
    Type: Grant
    Filed: August 19, 2011
    Date of Patent: December 6, 2016
    Assignees: Dana-Farber Cancer Institute. Inc., The Brigham and Women's Hospital. Inc., Children's Medical Center Corporation, The Technical University of Denmark
    Inventors: Andrea L. Richardson, Zhigang C. Wang, Daniel P. Silver, Zoltan Szallasi, Nicolai Juul Birkbak, Aron Charles Eklund
  • METHODS FOR PREDICTING ANTI-CANCER RESPONSE
    Publication number: 20150038340
    Abstract: The present invention is based, in part, on the identification of novel methods for defining predictive biomarkers of response to anti-cancer drugs.
    Type: Application
    Filed: August 22, 2014
    Publication date: February 5, 2015
    Inventors: Zoltan Szallasi, Nicolai Juul Birkbak, Aron Eklund, Daniel Silver, Zhigang Wang, Andrea Richardson
  • METHODS FOR PREDICTING ANTI-CANCER RESPONSE
    Publication number: 20130281312
    Abstract: The present invention is based, in part, on the identification of novel methods for defining predictive biomarkers of response to anti-cancer drugs.
    Type: Application
    Filed: August 19, 2011
    Publication date: October 24, 2013
    Applicants: DANA-FARBER CANCER INSTITUTE, INC., THE TECHNICAL UNIVERSITY OF DENMARK, CHILDREN'S MEDICAL CENTER CORPORATION, THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
    Inventors: Andrea L. Richardson, Zhingang C. Wang, Daniel P. Silver, Zoltan Szallasi, Nicolai Juul Birkbak, Aron Charles Eklund